G

Galectin Therapeutics
D

GALT

3.59000
USD
-0.10
(-2.58%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
362,050,222
أصول ذات صلة المقالات
المزيد

العنوان: Galectin Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.